Shanghai Runda Med Tech Co (603108) - Total Liabilities

Latest as of June 2025: CN¥8.41 Billion CNY ≈ $1.23 Billion USD

Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) has total liabilities worth CN¥8.41 Billion CNY (≈ $1.23 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Shanghai Runda Med Tech Co to assess how effectively this company generates cash.

Shanghai Runda Med Tech Co - Total Liabilities Trend (2014–2024)

This chart illustrates how Shanghai Runda Med Tech Co's total liabilities have evolved over time, based on quarterly financial data. Check 603108 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Shanghai Runda Med Tech Co Competitors by Total Liabilities

The table below lists competitors of Shanghai Runda Med Tech Co ranked by their total liabilities.

Company Country Total Liabilities
Kestra Medical Technologies, Ltd. Common Stock
NASDAQ:KMTS
USA $82.62 Million
Inrom Construction Industries Ltd
TA:INRM
Israel ILA718.26 Million
Ningbo Kangqiang Electronics Co Ltd
SHE:002119
China CN¥1.09 Billion
Blacksky Technology Inc
NYSE:BKSY
USA $292.41 Million
Fras-le S.A
SA:FRAS3
Brazil R$4.46 Billion
Godrej Agrovet Limited
NSE:GODREJAGRO
India Rs41.55 Billion
Teladoc Inc
NYSE:TDOC
USA $1.49 Billion
China Harzone Industry Corp Ltd
SHE:300527
China CN¥809.82 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Shanghai Runda Med Tech Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603108 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.61 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Runda Med Tech Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Runda Med Tech Co (2014–2024)

The table below shows the annual total liabilities of Shanghai Runda Med Tech Co from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥8.70 Billion
≈ $1.27 Billion
-1.82%
2023-12-31 CN¥8.86 Billion
≈ $1.30 Billion
-6.80%
2022-12-31 CN¥9.51 Billion
≈ $1.39 Billion
+24.72%
2021-12-31 CN¥7.62 Billion
≈ $1.12 Billion
+25.07%
2020-12-31 CN¥6.10 Billion
≈ $892.08 Million
+10.51%
2019-12-31 CN¥5.52 Billion
≈ $807.23 Million
+25.03%
2018-12-31 CN¥4.41 Billion
≈ $645.64 Million
+0.81%
2017-12-31 CN¥4.38 Billion
≈ $640.46 Million
+132.09%
2016-12-31 CN¥1.89 Billion
≈ $275.95 Million
+146.42%
2015-12-31 CN¥765.27 Million
≈ $111.98 Million
+25.60%
2014-12-31 CN¥609.27 Million
≈ $89.16 Million
--

About Shanghai Runda Med Tech Co

SHG:603108 China Diagnostics & Research
Market Cap
$1.21 Billion
CN¥8.25 Billion CNY
Market Cap Rank
#8360 Global
#2156 in China
Share Price
CN¥13.67
Change (1 day)
+1.79%
52-Week Range
CN¥12.26 - CN¥20.04
All Time High
CN¥26.34
About

Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more